Skip to main content
Viridian Therapeutics, Inc.\DE logo

Viridian Therapeutics, Inc.\DE — Investor Relations & Filings

Ticker · VRDN ISIN · US60463E1038 LEI · 549300C775BNYF550E70 US Professional, scientific and technical activities
Filings indexed 762 across all filing types
Latest filing 2026-05-05 Regulatory Filings
Country US United States of America
Listing US VRDN

About Viridian Therapeutics, Inc.\DE

https://www.viridiantherapeutics.com/

Viridian Therapeutics is a biopharmaceutical company that discovers, develops, and commercializes treatments for patients with serious and rare autoimmune diseases. The company leverages its expertise in antibody discovery and engineering to create optimized therapeutics. Its clinical pipeline is primarily focused on programs for Thyroid Eye Disease (TED) and includes a portfolio of neonatal Fc receptor (FcRn) inhibitors for a range of autoimmune conditions.

Recent filings

Filing Released Lang Actions
FWP - Viridian Therapeutics, Inc.\DE (0001590750) (Subject)
Regulatory Filings
2026-05-05 English
8-K - Viridian Therapeutics, Inc.\DE (0001590750) (Filer)
Regulatory Filings
2026-05-05 English
10-Q - Viridian Therapeutics, Inc.\DE (0001590750) (Filer)
Interim / Quarterly Report
2026-05-05 English
8-K - Viridian Therapeutics, Inc.\DE (0001590750) (Filer)
Regulatory Filings
2026-05-05 English
ARS - Viridian Therapeutics, Inc.\DE (0001590750) (Filer)
Annual Report
2026-04-17 English
DEF 14A - Viridian Therapeutics, Inc.\DE (0001590750) (Filer)
Proxy Solicitation & Information Statement
2026-04-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.